{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:32:25Z","timestamp":1792794745300,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04647-2","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T17:29:59Z","timestamp":1743701399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Liver biomarkers as predictors of prognosis in heart failure with preserved ejection fraction: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3386-7697","authenticated-orcid":false,"given":"Parham","family":"Dastjerdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6210-2112","authenticated-orcid":false,"given":"Mehrdad","family":"Mahalleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8450-4662","authenticated-orcid":false,"given":"Hedieh","family":"Shayesteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5041-6798","authenticated-orcid":false,"given":"Mohammad Sadeq","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9134-8787","authenticated-orcid":false,"given":"Roozbeh","family":"Narimani-Javid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3579-4181","authenticated-orcid":false,"given":"Mohadese","family":"Dashtkoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7849-3760","authenticated-orcid":false,"given":"Seyed Ali","family":"Mofidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5676-3099","authenticated-orcid":false,"given":"Kaveh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5286-9897","authenticated-orcid":false,"given":"Masih","family":"Tajdini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"issue":"10","key":"4647_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","volume":"14","author":"SM Dunlay","year":"2017","unstructured":"Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Reviews Cardiol. 2017;14(10):591\u2013602.","journal-title":"Nat Reviews Cardiol"},{"key":"4647_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11897-013-0155-7","volume":"10","author":"AA Oktay","year":"2013","unstructured":"Oktay AA, Rich JD, Shah SJ. The emerging epidemic of heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2013;10:401\u201310.","journal-title":"Curr Heart Fail Rep"},{"issue":"3","key":"4647_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.hfc.2021.03.002","volume":"17","author":"D-H Cho","year":"2021","unstructured":"Cho D-H, Yoo B-S. Current prevalence, incidence, and outcomes of heart failure with preserved ejection fraction. Heart Fail Clin. 2021;17(3):315\u201326.","journal-title":"Heart Fail Clin"},{"issue":"2","key":"4647_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/00325481.2020.1842621","volume":"133","author":"PP Toth","year":"2021","unstructured":"Toth PP, Gauthier D. Heart failure with preserved ejection fraction: disease burden for patients, caregivers, and the health-care system. Postgrad Med. 2021;133(2):140\u20135.","journal-title":"Postgrad Med"},{"key":"4647_CR5","doi-asserted-by":"publisher","first-page":"618816","DOI":"10.3389\/fcvm.2021.618816","volume":"8","author":"W Liang","year":"2021","unstructured":"Liang W, He X, Wu D, Xue R, Dong B, Owusu-Agyeman M, et al. Prognostic implication of liver function tests in heart failure with preserved ejection fraction without chronic hepatic diseases: insight from TOPCAT trial. Front Cardiovasc Med. 2021;8:618816.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"4647_CR6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ehf2.14211","volume":"10","author":"A Wang","year":"2023","unstructured":"Wang A, Li Z, Sun Z, Wang Y, Fu S, Zhang D, Ma X. Heart failure with preserved ejection fraction and non-alcoholic fatty liver disease: new insights from bioinformatics. ESC Heart Fail. 2023;10(1):416\u201331.","journal-title":"ESC Heart Fail"},{"issue":"2","key":"4647_CR7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/ehf2.13222","volume":"8","author":"R Itier","year":"2021","unstructured":"Itier R, Guillaume M, Ricci JE, Roubille F, Delarche N, Picard F, et al. Non-alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues. ESC Heart Fail. 2021;8(2):789\u201398.","journal-title":"ESC Heart Fail"},{"key":"4647_CR8","doi-asserted-by":"publisher","first-page":"748173","DOI":"10.3389\/fcvm.2021.748173","volume":"8","author":"J Zhang","year":"2021","unstructured":"Zhang J, Xu M, Chen T, Zhou Y. Correlation between liver stiffness and diastolic function, left ventricular hypertrophy, and right cardiac function in patients with ejection fraction preserved heart failure. Front Cardiovasc Med. 2021;8:748173.","journal-title":"Front Cardiovasc Med"},{"issue":"18","key":"4647_CR9","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.3390\/jcm12186017","volume":"12","author":"E Gremese","year":"2023","unstructured":"Gremese E, Bruno D, Varriano V, Perniola S, Petricca L, Ferraccioli G. Serum albumin levels: a biomarker to be repurposed in different disease settings in clinical practice. J Clin Med. 2023;12(18):6017.","journal-title":"J Clin Med"},{"issue":"3","key":"4647_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1515\/almed-2021-0047","volume":"2","author":"AR Guerra Ruiz","year":"2021","unstructured":"Guerra Ruiz AR, Crespo J, L\u00f3pez Mart\u00ednez RM, Iruzubieta P, Casals Mercadal G, Lalana Garc\u00e9s M, et al. Measurement and clinical usefulness of bilirubin in liver disease. Adv Lab Medicine\/Avances En Med De Laboratorio. 2021;2(3):352\u201361.","journal-title":"Adv Lab Medicine\/Avances En Med De Laboratorio"},{"issue":"2","key":"4647_CR11","first-page":"10","volume":"37","author":"T Constantin","year":"2011","unstructured":"Constantin T. Jaundice obstructive syndrome. Curr Health Sci J. 2011;37(2):10\u20133.","journal-title":"Curr Health Sci J"},{"issue":"2","key":"4647_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0016-5085(87)90123-5","volume":"92","author":"M Muraca","year":"1987","unstructured":"Muraca M, Fevery J, Blanckaert N. Relationships between serum bilirubins and production and conjugation of bilirubin: studies in Gilbert\u2019s syndrome, Crigler-Najjar disease, hemolytic disorders, and rat models. Gastroenterology. 1987;92(2):309\u201317.","journal-title":"Gastroenterology"},{"issue":"6","key":"4647_CR13","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3390\/life13061273","volume":"13","author":"R Chinnappan","year":"2023","unstructured":"Chinnappan R, Mir TA, Alsalameh S, Makhzoum T, Adeeb S, Al-Kattan K, Yaqinuddin A. Aptasensors are conjectured as promising ALT and AST diagnostic tools for the early diagnosis of acute liver injury. Life. 2023;13(6):1273.","journal-title":"Life"},{"issue":"1","key":"4647_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.58427\/apghn.2.1.2023.40-52","volume":"2","author":"YS Ermaya","year":"2023","unstructured":"Ermaya YS, Prasetyo D. How to interpret liver function test in daily practice. Archives Pediatr Gastroenterol Hepatol Nutr. 2023;2(1):40\u201352.","journal-title":"Archives Pediatr Gastroenterol Hepatol Nutr"},{"issue":"2","key":"4647_CR15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ehf2.12222","volume":"5","author":"A Yoshihisa","year":"2018","unstructured":"Yoshihisa A, Sato Y, Yokokawa T, Sato T, Suzuki S, Oikawa M, et al. Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction. ESC Heart Fail. 2018;5(2):262\u201370.","journal-title":"ESC Heart Fail"},{"issue":"8","key":"4647_CR16","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/ejhf.2922","volume":"25","author":"M B\u00f6hm","year":"2023","unstructured":"B\u00f6hm M, Butler J, Krawczyk M, Mahfoud F, Haring B, Filippatos G, et al. Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: the EMPEROR-Preserved trial. Eur J Heart Fail. 2023;25(8):1375\u201383.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"4647_CR17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.amjcard.2019.11.006","volume":"125","author":"SB Prenner","year":"2020","unstructured":"Prenner SB, Kumar A, Zhao L, Cvijic ME, Basso M, Spires T, et al. Effect of serum albumin levels in patients with heart failure with preserved ejection fraction (from the TOPCAT trial). Am J Cardiol. 2020;125(4):575\u201382.","journal-title":"Am J Cardiol"},{"issue":"10","key":"4647_CR18","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.amjcard.2018.01.040","volume":"121","author":"VV Georgiopoulou","year":"2018","unstructured":"Georgiopoulou VV, Velayati A, Burkman G, Li S, Farooq K, Samman-Tahhan A, et al. Comorbidities, sociodemographic factors, and hospitalizations in outpatients with heart failure and preserved ejection fraction. Am J Cardiol. 2018;121(10):1207\u201313.","journal-title":"Am J Cardiol"},{"issue":"4","key":"4647_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"JA Hayden","year":"2013","unstructured":"Hayden JA, van der Windt DA, Cartwright JL, C\u00f4t\u00e9 P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158(4):280\u20136.","journal-title":"Ann Intern Med"},{"issue":"2","key":"4647_CR20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","volume":"65","author":"SM Francque","year":"2016","unstructured":"Francque SM, Van Der Graaff D, Kwanten WJ. Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications. J Hepatol. 2016;65(2):425\u201343.","journal-title":"J Hepatol"},{"issue":"11","key":"4647_CR21","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.jacbts.2021.07.010","volume":"6","author":"HM Salah","year":"2021","unstructured":"Salah HM, Pandey A, Soloveva A, Abdelmalek MF, Diehl AM, Moylan CA, et al. Relationship of nonalcoholic fatty liver disease and heart failure with preserved ejection fraction. Basic Translational Sci. 2021;6(11):918\u201332.","journal-title":"Basic Translational Sci"},{"issue":"5","key":"4647_CR22","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1002\/hep.32072","volume":"74","author":"J Zhou","year":"2021","unstructured":"Zhou J, Bai L, Zhang XJ, Li H, Cai J. Nonalcoholic fatty liver disease and cardiac remodeling risk: pathophysiological mechanisms and clinical implications. Hepatology. 2021;74(5):2839\u201347.","journal-title":"Hepatology"},{"issue":"1","key":"4647_CR23","doi-asserted-by":"publisher","first-page":"12440","DOI":"10.1038\/s41598-020-69013-y","volume":"10","author":"A Miller","year":"2020","unstructured":"Miller A, McNamara J, Hummel SL, Konerman MC, Tincopa MA. Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction. Sci Rep. 2020;10(1):12440.","journal-title":"Sci Rep"},{"issue":"3","key":"4647_CR24","doi-asserted-by":"publisher","first-page":"e032997","DOI":"10.1161\/JAHA.123.032997","volume":"13","author":"XD Zhou","year":"2024","unstructured":"Zhou XD, Chen QF, Targher G, Byrne CD, Shapiro MD, Tian N, et al. High-sensitivity C\u2010reactive protein is associated with heart failure hospitalization in patients with metabolic dysfunction\u2010associated fatty liver disease and normal left ventricular ejection fraction undergoing coronary angiography. J Am Heart Association. 2024;13(3):e032997.","journal-title":"J Am Heart Association"},{"key":"4647_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11897-013-0166-4","volume":"10","author":"AM Shah","year":"2013","unstructured":"Shah AM. Ventricular remodeling in heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2013;10:341\u20139.","journal-title":"Curr Heart Fail Rep"},{"key":"4647_CR26","doi-asserted-by":"crossref","unstructured":"Lam CS, Brutsaert DL. Endothelial dysfunction: a pathophysiologic factor in heart failure with preserved ejection fraction. American College of Cardiology Foundation Washington, DC; 2012. pp. 1787\u20139.","DOI":"10.1016\/j.jacc.2012.08.004"},{"key":"4647_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.amjcard.2022.02.012","volume":"171","author":"HM Salah","year":"2022","unstructured":"Salah HM, Pandey A, Van Spall HG, Michos ED, McGarrah RW, Fudim M. Meta-analysis of nonalcoholic fatty liver disease and incident heart failure. Am J Cardiol. 2022;171:180.","journal-title":"Am J Cardiol"},{"issue":"8","key":"4647_CR28","doi-asserted-by":"publisher","first-page":"101199","DOI":"10.1016\/j.cpcardiol.2022.101199","volume":"48","author":"AMK Minhas","year":"2023","unstructured":"Minhas AMK, Bhopalwala HM, Dewaswala N, Salah HM, Khan MS, Shahid I, et al. Association of non-alcoholic fatty liver disease with in-hospital outcomes in primary heart failure hospitalizations with reduced or preserved ejection fraction. Curr Probl Cardiol. 2023;48(8):101199.","journal-title":"Curr Probl Cardiol"},{"issue":"1","key":"4647_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","volume":"42","author":"PR Lawler","year":"2021","unstructured":"Lawler PR, Bhatt DL, Godoy LC, L\u00fcscher TF, Bonow RO, Verma S, Ridker PM. Targeting cardiovascular inflammation: next steps in clinical translation. Eur Heart J. 2021;42(1):113\u201331.","journal-title":"Eur Heart J"},{"issue":"2","key":"4647_CR30","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/ehf2.13250","volume":"8","author":"AE Peters","year":"2021","unstructured":"Peters AE, Pandey A, Ayers C, Wegermann K, McGarrah RW, Grodin JL, et al. Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT. ESC Heart Fail. 2021;8(2):842\u20138.","journal-title":"ESC Heart Fail"},{"key":"4647_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2017.02.003","volume":"259","author":"Y Li","year":"2017","unstructured":"Li Y, Zhong X, Cheng G, Zhao C, Zhang L, Hong Y, et al. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: a meta-analysis. Atherosclerosis. 2017;259:75\u201382.","journal-title":"Atherosclerosis"},{"key":"4647_CR32","doi-asserted-by":"crossref","unstructured":"Gu H-Q, Yang K-X, Lin J-X, Jing J, Zhao X-Q, Wang Y-L et al. Association between high-sensitivity C-reactive protein, functional disability, and stroke recurrence in patients with acute ischaemic stroke: A mediation analysis. EBioMedicine. 2022;80.","DOI":"10.1016\/j.ebiom.2022.104054"},{"issue":"1","key":"4647_CR33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cjca.2021.10.007","volume":"38","author":"M Lee","year":"2022","unstructured":"Lee M, Lee K, Kim D-W, Cho JS, Kim T-S, Kwon J, et al. Relationship of serial high-sensitivity C-Reactive protein changes to long-term clinical outcomes in stabilised patients after myocardial infarction. Can J Cardiol. 2022;38(1):92\u2013101.","journal-title":"Can J Cardiol"},{"issue":"1","key":"4647_CR34","doi-asserted-by":"publisher","first-page":"5386","DOI":"10.1038\/s41598-024-55996-5","volume":"14","author":"R Zhou","year":"2024","unstructured":"Zhou R, Xia Y-Y, Li Z, Wu L-D, Shi Y, Ling Z-Y, Zhang J-X. HFpEF as systemic disease, insight from a diagnostic prediction model reminiscent of systemic inflammation and organ interaction in HFpEF patients. Sci Rep. 2024;14(1):5386.","journal-title":"Sci Rep"},{"issue":"1","key":"4647_CR35","first-page":"101465","volume":"4","author":"HE Billingsley","year":"2025","unstructured":"Billingsley HE, Carbone S, Driggin E, Kitzman DW, Hummel SL. Dietary interventions in heart failure with preserved ejection fraction: A scoping review. JACC: Adv. 2025;4(1):101465.","journal-title":"JACC: Adv"},{"issue":"3","key":"4647_CR36","doi-asserted-by":"publisher","first-page":"e014716","DOI":"10.1161\/JAHA.119.014716","volume":"9","author":"SB Prenner","year":"2020","unstructured":"Prenner SB, Pillutla R, Yenigalla S, Gaddam S, Lee J, Obeid MJ, et al. Serum albumin is a marker of myocardial fibrosis, adverse pulsatile aortic hemodynamics, and prognosis in heart failure with preserved ejection fraction. J Am Heart Association. 2020;9(3):e014716.","journal-title":"J Am Heart Association"},{"issue":"1","key":"4647_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/eurjhf\/hfr154","volume":"14","author":"M Liu","year":"2012","unstructured":"Liu M, Chan CP, Yan BP, Zhang Q, Lam YY, Li RJ, et al. Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2012;14(1):39\u201344.","journal-title":"Eur J Heart Fail"},{"key":"4647_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejim.2022.05.004","volume":"102","author":"AA Manolis","year":"2022","unstructured":"Manolis AA, Manolis TA, Melita H, Mikhailidis DP, Manolis AS. Low serum albumin: A neglected predictor in patients with cardiovascular disease. Eur J Intern Med. 2022;102:24\u201339.","journal-title":"Eur J Intern Med"},{"issue":"6","key":"4647_CR39","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.ahj.2010.09.004","volume":"160","author":"S Uthamalingam","year":"2010","unstructured":"Uthamalingam S, Kandala J, Daley M, Patvardhan E, Capodilupo R, Moore SA, Januzzi JL Jr. Serum albumin and mortality in acutely decompensated heart failure. Am Heart J. 2010;160(6):1149\u201355.","journal-title":"Am Heart J"},{"issue":"1","key":"4647_CR40","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12872-022-02797-1","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang L, Zhao Y-T. Albumin infusion in hospitalized patients with acute heart failure: a retrospective cohort study. BMC Cardiovasc Disord. 2022;22(1):358.","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"4647_CR41","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/01.SLA.0000055547.93484.87","volume":"237","author":"J-L Vincent","year":"2003","unstructured":"Vincent J-L, Dubois M-J, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there A rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237(3):319\u201334.","journal-title":"Ann Surg"},{"issue":"5","key":"4647_CR42","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/j.clnu.2017.07.009","volume":"37","author":"E Ramiro-Ortega","year":"2018","unstructured":"Ramiro-Ortega E, Bonilla-Palomas JL, G\u00e1mez-L\u00f3pez AL, Moreno-Conde M, L\u00f3pez-Ib\u00e1\u00f1ez MC, Alhambra-Exp\u00f3sito R, S\u00e1nchez MA. Nutritional intervention in acute heart failure patients with undernutrition and normalbuminemia: a subgroup analysis of PICNIC study. Clin Nutr. 2018;37(5):1762\u20134.","journal-title":"Clin Nutr"},{"issue":"7","key":"4647_CR43","doi-asserted-by":"publisher","first-page":"e0219044","DOI":"10.1371\/journal.pone.0219044","volume":"14","author":"S Suzuki","year":"2019","unstructured":"Suzuki S, Hashizume N, Kanzaki Y, Maruyama T, Kozuka A, Yahikozawa K. Prognostic significance of serum albumin in patients with stable coronary artery disease treated by percutaneous coronary intervention. PLoS ONE. 2019;14(7):e0219044.","journal-title":"PLoS ONE"},{"key":"4647_CR44","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s00380-017-0981-8","volume":"32","author":"H Wada","year":"2017","unstructured":"Wada H, Dohi T, Miyauchi K, Shitara J, Endo H, Doi S, et al. Impact of serum albumin levels on long-term outcomes in patients undergoing percutaneous coronary intervention. Heart Vessels. 2017;32:1085\u201392.","journal-title":"Heart Vessels"},{"issue":"4","key":"4647_CR45","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jjcc.2019.08.019","volume":"75","author":"A Shiyovich","year":"2020","unstructured":"Shiyovich A, Bental T, Assali A, Vaknin-Assa H, Kornowski R, Perl L. Changes over time in serum albumin levels predict outcomes following percutaneous coronary intervention. J Cardiol. 2020;75(4):381\u20136.","journal-title":"J Cardiol"},{"issue":"Supplement1","key":"4647_CR46","first-page":"ehab724","volume":"42","author":"L Cowan","year":"2021","unstructured":"Cowan L, Adamson C, Docherty K, Inzucchi S, Koeber L, Kosiborod M, et al. Elevated markers of liver function are associated with poorer outcomes in HFREF: an analysis of DAPA-HF. Eur Heart J. 2021;42(Supplement1):ehab724.","journal-title":"Eur Heart J"},{"issue":"suppl1","key":"4647_CR47","first-page":"A20954","volume":"136","author":"J Solanki","year":"2017","unstructured":"Solanki J, Bilchick K, Wynter J, Parker A, Mwansa H, Kennedy J, et al. Abnormal liver function tests are association with adverse outcomes in acute decompensated heart failure in the CARRESS trial. Circulation. 2017;136(suppl1):A20954\u2013A.","journal-title":"Circulation"},{"issue":"3","key":"4647_CR48","doi-asserted-by":"publisher","first-page":"429","DOI":"10.5507\/bp.2014.014","volume":"159","author":"K Vyskocilova","year":"2015","unstructured":"Vyskocilova K, Spinarova L, Spinar J, Mikusova T, Vitovec J, Malek J, et al. Prevalence and clinical significance of liver function abnormalities in patients with acute heart failure. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159(3):429\u201336.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"1","key":"4647_CR49","doi-asserted-by":"publisher","first-page":"18541","DOI":"10.1038\/s41598-019-55116-8","volume":"9","author":"D Dalos","year":"2019","unstructured":"Dalos D, Binder C, Duca F, Aschauer S, Kammerlander A, Hengstenberg C, et al. Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction. Sci Rep. 2019;9(1):18541.","journal-title":"Sci Rep"},{"issue":"4","key":"4647_CR50","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1536\/ihj.21-025","volume":"62","author":"Y Saito","year":"2021","unstructured":"Saito Y, Matsumoto N, Aizawa Y, Fukamachi D, Kitano D, Toyama K, et al. Prognostic value of liver stiffness measured by Two-Dimensional elastography in acute decompensated heart failure with preserved ejection fraction. Int Heart J. 2021;62(4):821\u20138.","journal-title":"Int Heart J"},{"key":"4647_CR51","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.2147\/JIR.S452544","volume":"17","author":"MD Cheng","year":"2024","unstructured":"Cheng MD, Zheng YY, Zhang XY, Ruzeguli T, Sureya Y, Didaer Y, et al. The simplified Thrombo-Inflammatory score as a novel predictor of All-Cause mortality in patients with heart failure: A retrospective cohort study. J Inflamm Res. 2024;17:1845\u201355.","journal-title":"J Inflamm Res"},{"key":"4647_CR52","doi-asserted-by":"crossref","unstructured":"Cheng YL, Sung SH, Cheng HM, Hsu PF, Guo CY, Yu WC, Chen CH. Prognostic nutritional index and the risk of mortality in patients with acute heart failure. J Am Heart Assoc. 2017;6(6).","DOI":"10.1161\/JAHA.116.004876"},{"issue":"5","key":"4647_CR53","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/ehf2.12501","volume":"6","author":"SC Chien","year":"2019","unstructured":"Chien SC, Lo CI, Lin CF, Sung KT, Tsai JP, Huang WH, et al. Malnutrition in acute heart failure with preserved ejection fraction: clinical correlates and prognostic implications. ESC Heart Fail. 2019;6(5):953\u201364.","journal-title":"ESC Heart Fail"},{"issue":"8","key":"4647_CR54","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00380-021-01788-0","volume":"36","author":"A Fuchida","year":"2021","unstructured":"Fuchida A, Suzuki S, Motoki H, Kanzaki Y, Maruyama T, Hashizume N, et al. Prognostic significance of diastolic blood pressure in patients with heart failure with preserved ejection fraction. Heart Vessels. 2021;36(8):1159\u201365.","journal-title":"Heart Vessels"},{"key":"4647_CR55","doi-asserted-by":"crossref","unstructured":"Hoshida S, Hikoso S, Shinoda Y, Tachibana K, Minamisaka T, Tamaki S et al. Diastolic index as a short-term prognostic factor in heart failure with preserved ejection fraction. Open Heart. 2020;7(2).","DOI":"10.1136\/openhrt-2020-001469"},{"key":"4647_CR56","doi-asserted-by":"crossref","unstructured":"Matsuo N, Miyoshi T, Takaishi A, Kishinoue T, Yasuhara K, Tanimoto M et al. High plasma docosahexaenoic acid associated to better prognoses of patients with acute decompensated heart failure with preserved ejection fraction. Nutrients. 2021;13(2).","DOI":"10.3390\/nu13020371"},{"issue":"3","key":"4647_CR57","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/ehf2.13293","volume":"8","author":"M Nishino","year":"2021","unstructured":"Nishino M, Yano M, Ukita K, Kawamura A, Nakamura H, Matsuhiro Y, et al. Impact of readmissions on octogenarians with heart failure with preserved ejection fraction: PURSUIT-HFpEF registry. ESC Heart Fail. 2021;8(3):2120\u201332.","journal-title":"ESC Heart Fail"},{"issue":"1","key":"4647_CR58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1253\/circj.CJ-21-0300","volume":"86","author":"B Oeun","year":"2022","unstructured":"Oeun B, Hikoso S, Nakatani D, Mizuno H, Suna S, Kitamura T, et al. Prognostic impact of echocardiographic diastolic dysfunction on outcomes in patients with heart failure with preserved ejection Fraction - Insights from the PURSUIT-HFpEF registry. Circ J. 2022;86(1):23\u201333.","journal-title":"Circ J"},{"issue":"10","key":"4647_CR59","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/ejhf.2607","volume":"24","author":"SJ Pocock","year":"2022","unstructured":"Pocock SJ, Ferreira JP, Packer M, Zannad F, Filippatos G, Kondo T, et al. Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial. Eur J Heart Fail. 2022;24(10):1869\u201378.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"4647_CR60","doi-asserted-by":"publisher","first-page":"e014716","DOI":"10.1161\/JAHA.119.014716","volume":"9","author":"SB Prenner","year":"2020","unstructured":"Prenner SB, Pillutla R, Yenigalla S, Gaddam S, Lee J, Obeid MJ, et al. Serum albumin is a marker of myocardial fibrosis, adverse pulsatile aortic hemodynamics, and prognosis in heart failure with preserved ejection fraction. J Am Heart Assoc. 2020;9(3):e014716.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"4647_CR61","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1007\/s00392-020-01786-8","volume":"110","author":"L Shen","year":"2021","unstructured":"Shen L, Jhund PS, Anand IS, Carson PE, Desai AS, Granger CB, et al. Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction. Clin Res Cardiol. 2021;110(8):1234\u201348.","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"4647_CR62","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1002\/ehf2.13351","volume":"8","author":"M Takae","year":"2021","unstructured":"Takae M, Fujisue K, Yamamoto E, Egashira K, Komorita T, Oike F, et al. Prognostic significance of liver stiffness assessed by fibrosis-4 index in patients with heart failure. ESC Heart Fail. 2021;8(5):3809\u201321.","journal-title":"ESC Heart Fail"},{"issue":"5","key":"4647_CR63","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/00015385.2019.1661139","volume":"75","author":"H Zencirkiran Agus","year":"2020","unstructured":"Zencirkiran Agus H, Kahraman S. Prognostic nutritional index predicts one-year outcome in heart failure with preserved ejection fraction. Acta Cardiol. 2020;75(5):450\u20135.","journal-title":"Acta Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04647-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04647-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04647-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T05:10:32Z","timestamp":1743743432000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04647-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4647"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04647-2","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study is a systematic review and meta-analysis that utilized previously published and peer-reviewed material. Therefore, no ethical approval or consent to participate was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. As this study relied solely on previously published data, no individual person\u2019s data, images, or videos were included that would require consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}